Sort
30,917 grants matching “tumor microenvironment”
Environmental Effect on the Mammary Gland across the Lifespan
$464,308Zena Werb · University Of California, San Francisco · U01 · FY2012 · ES
Functional Cooperation of Tissue Factor and Integrins
$464,275Wolfram Ruf · Scripps Research Institute, The · R01 · FY2014 · HL
Phenotype Interactions and Dynamics in SCLC Tumors
$464,274Alissa M Weaver · Vanderbilt University · U54 · FY2018 · CA
Modeling immunity with a hybrid lymph node tissue-chip
$464,241Rebecca R Pompano · University Of Virginia · R01 · FY2022 · AI
Targeting autophagy to enhance immune checkpoint inhibition
$464,236Ravi K Amaravadi · Wistar Institute · P50 · FY2024 · CA
Racial differences in Immunogenetic Tumorigenesis of Head and Neck Squamous Cell Carcinoma
$464,222David Sidransky · Johns Hopkins University · R01 · FY2023 · CA
An image-guided immunotherapy and hyperthermia delivery device to overcome barriers to tumor immunity for advanced hepatocellular carcinoma
$464,218Rahul Anil Sheth · University Of Tx Md Anderson Can Ctr · R37 · FY2025 · CA
Project 1- Elucidating oncogenic KRAS in PDAC cell signaling, resistance and immunity
$464,161Ronald Anthony Depinho · University Of Tx Md Anderson Can Ctr · P01 · FY2025 · CA
Targeting S6K2 to Overcome Drug Resistance in NRAS-mutant Melanoma
$464,112Jessie Villanueva · Wistar Institute · R01 · FY2024 · CA
Conserved Biology of Tumor and Microenvironment in Breast Cancer Progression
$464,025Charles M Perou · Univ Of North Carolina Chapel Hill · R01 · FY2011 · CA
Cooperative role of TET2 and IDH2 mutations in angioimmunoblastic T-cell lymphomagenesis
$463,981Javeed Iqbal · University Of Nebraska Medical Center · R01 · FY2024 · CA
Immunometabolic pathways enabled by PARP inhibition in breast cancer
$463,884Jennifer L. Guerriero · Brigham And Women'S Hospital · R37 · FY2023 · CA
Understanding Metabolic and Epigenetic Crossâ talk in Potent Antiâ tumor T cells
$463,746Shikhar Mehrotra · Medical University Of South Carolina · R01 · FY2020 · CA
Understanding Metabolic and Epigenetic Crossâ talk in Potent Antiâ tumor T cells
$463,746Shikhar Mehrotra · Medical University Of South Carolina · R01 · FY2021 · CA
TGF-Beta Suppression and Promotion of Mammary Carcinomas
$463,737Harold L Moses · Vanderbilt University · R01 · FY2010 · CA
Targeting Neoantigens in Glioblastoma
$463,723Gavin Peter Dunn · Washington University · R01 · FY2021 · NS
Ras-mediated signals in human epithelial cell transformation and metastasis
$463,709Kathleen Kelly · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Defining the role of CNPY2 in promoting tumor progression through mediation of macrophage.
$463,704Feng Hong · Ohio State University · R01 · FY2025 · CA
Defining the role of CNPY2 in promoting tumor progression through mediation of macrophage.
$463,704Feng Hong · Ohio State University · R01 · FY2023 · CA
Neural Niche in Promoting Brain Metastatic Tumor Progression
$463,695Siyuan Zhang · Ut Southwestern Medical Center · R01 · FY2023 · CA
Rapid and flexible precision oncology mouse models of epithelial malignancies epithelial malignancies
$463,686Scott W Lowe · Sloan-Kettering Inst Can Research · R01 · FY2024 · CA
Understanding the effect of aging on the lung adenocarcinoma tumor microenvironment
$463,625Alexander Minchev Tsankov · Icahn School Of Medicine At Mount Sinai · R21 · FY2025 · AG
Therapeutic Targeting of Macrophage PI3Kgamma in HNSCC
$463,621Judith A. Varner · University Of California, San Diego · R01 · FY2022 · CA
Mechanism of Intratumoral Transport of Particulate Drugs
$463,570Haifa Shen · Methodist Hospital Research Institute · R01 · FY2021 · CA
Mapping cancer micro-environments for acute leukemia
$463,557Iannis Aifantis · New York University School Of Medicine · R01 · FY2016 · CA